Enlitic, Inc.
Enlitic, Inc.
Your view on ENL.AX
Overview
What the company does, where it operates, and who runs it.
About Enlitic, Inc.
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Michael Karlgerhard Sistenich
- Headquarters
- 2510 East Harmony Road, Fort Collins, CO, US
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Michael Karlgerhard Sistenich
- Headquarters
- 2510 East Harmony Road, Fort Collins, CO, US
Enlitic, Inc., headquartered in Fort Collins, Colorado, is a company operating in the healthcare sector across the United States, Europe, and Japan. Specializing in artificial intelligence (AI), Enlitic develops sophisticated software solutions engineered to manage and optimize medical imaging data within radiology, covering modalities such as magnetic resonance imaging (MRI), computed tomography (CT) scans, and ultrasound. The company licenses these AI-powered solutions to both healthcare providers and original equipment manufacturers (OEMs). Its comprehensive suite of healthcare data solutions includes ENDEX, an AI platform designed to standardize diverse medical imaging data; ENCOG, an AI-enabled solution for data anonymization that effectively safeguards protected health information (PHI) while preserving crucial clinical insights in imaging studies; and Migratek, an AI-driven data migration solution, complemented by routing services. Enlitic's offerings are specifically tailored to support healthcare IT departments, hospital executives, and clinical researchers. Incorporated in 2014, the company was previously known as You Partners, Inc.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for Enlitic, Inc., and the rating behind it. ENL.AX last traded at AUD 0.0040; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Enlitic, Inc.. Starting points for Enlitic, Inc.: EPS -AUD 0.03, beta -0.47 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Enlitic, Inc.. Enlitic, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Enlitic, Inc.. Trailing twelve-month EPS for Enlitic, Inc. stands at -AUD 0.03. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Enlitic, Inc.. Enlitic, Inc. has reported as a listed company since 2023. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Enlitic, Inc. valued side by side against its closest peers. Enlitic, Inc. is measured against Medical - Healthcare Information Services peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Enlitic, Inc., and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Enlitic, Inc. executives and directors. Shares of Enlitic, Inc. have traded between AUD 0.0030 and AUD 0.05 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Enlitic, Inc.. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Enlitic, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Enlitic, Inc.. Coverage tracks Enlitic, Inc. within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.